Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PFE vs MRNA✓SelectedUSD · MRNAPFE vs MRNA performance historyLatest closeAs of-0.51%11/20
Stock and ETF performance explorer

PFE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+11.0%
MRNA return
+153.9%
Excess return
-142.9%
Maximum drawdown
-29.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.5%-2.2%+1.7%-0.4%
7D-5.2%-12.7%+7.5%-4.5%
30D-6.9%-20.7%+13.8%-6.0%
3M0.0%+46.3%-46.2%-2.4%
6M+9.7%+305.2%-295.6%-5.3%
YTD+17.4%+561.2%-543.8%-7.8%
1Y+19.8%+772.1%-752.3%-10.4%
3Y+11.0%+147.0%-136.0%-1.4%
All+11.0%+153.9%-142.9%-1.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling